Erik Klapproth

Waehringer Str. 42
Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.

Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.

Journal: Basic research in cardiology

Published: April 27, 2026

Remodeling of ferroptotic necroinflammation by dexamethasone in acute tubular necrosis.

Remodeling of ferroptotic necroinflammation by dexamethasone in acute tubular necrosis.

Journal: Cell death & disease

Published: January 12, 2026

Why C-reactive protein is (usually) not high in SLE

Why C-reactive protein is (usually) not high in SLE

Journal: Zeitschrift fur Rheumatologie

Published: October 06, 2025

The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.

The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.

Journal: Basic research in cardiology

Published: January 30, 2025

Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors.

Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors.

Journal: Rheumatology (Oxford, England)

Published: January 27, 2025

Leveraging the ADAM10 prodomain for selective inhibition to enhance recovery after myocardial infarction.

Leveraging the ADAM10 prodomain for selective inhibition to enhance recovery after myocardial infarction.

Journal: British journal of pharmacology

Published: November 28, 2024

Correction to: Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesis.

Correction to: Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesis.

Journal: Pflugers Archiv : European journal of physiology

Published: November 27, 2024

Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine.

Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine.

Journal: Scientific reports

Published: May 21, 2024

Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesis.

Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesis.

Journal: Pflugers Archiv : European journal of physiology

Published: December 05, 2023

Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice.

Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice.

Journal: Physiological reports

Published: June 23, 2023

CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2.

CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2.

Journal: Circulation research

Published: January 30, 2023

Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction.

Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction.

Journal: Nature communications

Published: May 09, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026